Why the study?
The study aimed to investigate the long-term impact of left atrial appendage occlusion on cardiac function and structure in patients with non-valvular atrial fibrillation.
Does LAAO combined with ablation improve cardiac structure and function compared to LAAO alone in patients with non-valvular atrial fibrillation?
Does LAAO combined with ablation improve cardiac structure and function compared to LAAO alone in patients with non-valvular atrial fibrillation?
LAAO combined with ablation significantly improves cardiac structure and function in patients with NVAF compared to LAAO alone, with the benefits primarily attributable to the ablation procedure.
May support adding ablation to LAAO for remodeling in NVAF; hypothesis-generating and requires randomized confirmation.
The Aim of this study was to investigate the long-term impact of left atrial appendage occlusion (LAAO) on cardiac function and structure in patients with non-valvular atrial fibrillation (NVAF). 157 patients with NVAF who underwent LAAO or combined with ablation were included and divided into simple LAAO group or combined group. Long term impact of LAAO on cardiac function and structure were evaluated. Results showed that the procedures were performed successfully with 6.4% complications. During follow-up, there was a significant decrease of left atrial anteroposterior diameter (LAAD) at 6 months and a significant increase of left ventricular end-diastolic dimension (LVEDD) at 12 months after LAAO. A significant decrease in plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) was noted at 3 months, 6 months and 12 months after procedure. There was a significant decrease of LAAD, LVEDD, left ventricular end-systolic dimension (LVESD) and NT-proBNP levels in combined group at 3 months, 6 months and 12 months post- procedure, while an increase of left ventricular ejection fraction (LVEF). Meanwhile, no significant change of LAAD, LVEDD, LVESD, NT-proBNP and LVEF was seen in simple LAAO group at 3 months follow-up, but a decrease of NT-proBNP during 6 months and 12 months follow-up. Compared with simple LAAO group, combined group was associated with a significant increase of residual flow. In conclusion, LAAO has no significant effect on cardiac structure and function but can significantly reduce NT-proBNP. The improvement of cardiac structure and function in combined therapy comes from the result of ablation, not LAAO.
No takes yet. Share an insight, caveat, or question.
Ruan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: